Kam-Yuen Au
Nessuna posizione attualmente
Profilo
Kam-Yuen Au served as Vice President-Controller at KLA Corp.
and Tesla Motors HK Ltd.
He was also Chief Financial Officer at Computime Group Ltd.
and Chief Operating Officer at DiagCor Bioscience, Inc. Ltd.
Additionally, he held the position of Vice President-Finance at Gilead Sciences Hong Kong Ltd.
Mr. Au holds a Master's in Business Administration from The University of Chicago and an undergraduate degree from the University of California, Berkeley.
Precedenti posizioni note di Kam-Yuen Au
Società | Posizione | Fine |
---|---|---|
Tesla Motors HK Ltd. | Comptroller/Controller/Auditor | - |
KLA CORPORATION | Comptroller/Controller/Auditor | - |
DiagCor Bioscience, Inc. Ltd.
DiagCor Bioscience, Inc. Ltd. Medical SpecialtiesHealth Technology DiagCor Bioscience, Inc. Ltd. develops and commercializes in vitro diagnostic kits and instruments. It offers a complete platform for commercial and clinical MDx diagnosis. The firm serves clinical diagnostic services markets in Latin America, Europe, Middle East and South East Asia. Its products include R2-M flow-through hybridization system, FT-PRO flow-through hybridization system, capture-PRO image capture system, Taigen VacEZor and FT-PRO auto system. The company was founded by Joseph Wing On Tam in 2006 and is headquartered in Hong Kong. | Direttore operativo | - |
Gilead Sciences Hong Kong Ltd. | Corporate Officer/Principal | - |
COMPUTIME GROUP LIMITED | Direttore Finanziario/CFO | 01/01/2018 |
Formazione di Kam-Yuen Au
The University of Chicago | Masters Business Admin |
University of California, Berkeley | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
KLA CORPORATION | Electronic Technology |
COMPUTIME GROUP LIMITED | Electronic Technology |
Aziende private | 3 |
---|---|
DiagCor Bioscience, Inc. Ltd.
DiagCor Bioscience, Inc. Ltd. Medical SpecialtiesHealth Technology DiagCor Bioscience, Inc. Ltd. develops and commercializes in vitro diagnostic kits and instruments. It offers a complete platform for commercial and clinical MDx diagnosis. The firm serves clinical diagnostic services markets in Latin America, Europe, Middle East and South East Asia. Its products include R2-M flow-through hybridization system, FT-PRO flow-through hybridization system, capture-PRO image capture system, Taigen VacEZor and FT-PRO auto system. The company was founded by Joseph Wing On Tam in 2006 and is headquartered in Hong Kong. | Health Technology |
Tesla Motors HK Ltd. | |
Gilead Sciences Hong Kong Ltd. |
- Borsa valori
- Insiders
- Kam-Yuen Au